At Siemens Healthineers, we pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably. As a leader in medical technology, we want to advance a world in which breakthroughs in healthcare create new possibilities with a minimal impact on our planet. By consistently bringing innovations to the market, we enable healthcare professionals to innovate personalised care, achieve operational excellence and transform the system of care.

Our portfolio, spanning in vitro and in vivo diagnostics to image-guided therapy and cancer care, is crucial for clinical decision-making and treatment pathways. With the unique combination of our strengths in patient twinning, precision therapy, as well as digital, data and artificial intelligence (AI), we are well positioned to take on the greatest challenges in healthcare. We will continue to build on these strengths to help overcome the world’s most threatening diseases, enable efficient operations, and expand access to care.

As a science company with over 100 years of expertise in diagnostic imaging, Bayer are committed to developing innovative products, software, and services to help Radiology departments operate at a high level of care.  Technologically advanced injectors for CT, MR, cardiovascular imaging and nuclear medicine, and MRI contrast media are supported by a digital ecosystem of software and workflow solutions that securely manages detailed patient data, contrast data and scan data.

Bayer offers all this with expert service to ensure Radiology ecosystems are maintained to a high standard including remote support for rapid assistance.  Bayer technologies come together as an end-to-end workflow solution with the aim of helping Radiology departments achieve consistent scan results, increased diagnostic confidence and operational efficiency for the benefit of patient care.

Bayer’s Radiology business is well placed to be the partner of choice in helping radiology services address the many challenges faced today.

Contact Number: 0118 2063999

PP-PF-RAD-GB-0798    April 2024